AGEN - Agenus Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
4.26
-0.07 (-1.62%)
At close: 4:00PM EDT

4.30 +0.04 (0.94%)
After hours: 7:40PM EDT

Stock chart is not supported by your current browser
Previous Close4.33
Open4.86
Bid4.27 x 1400
Ask4.31 x 100
Day's Range4.20 - 4.90
52 Week Range3.20 - 5.98
Volume12,032,792
Avg. Volume1,103,709
Market Cap422.25M
Beta2.92
PE Ratio (TTM)-3.38
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNBC42 minutes ago

    Cramer Remix: The oil market is alive and may be ready to start kicking

    Jim Cramer drilled into Schlumberger’s stock and what the company’s latest commentary means for the industry as a whole.

  • Why Agenus Inc. Stock Briefly Popped Today
    Motley Fool8 hours ago

    Why Agenus Inc. Stock Briefly Popped Today

    After the market had time to reflect on Agenus' new CAR-T venture, investors were unimpressed by its prospects.

  • Benzinga11 hours ago

    The Week Ahead: Earnings Season Starts In Earnest

    Below is a list of notable corporate events for the week beginning October 23. Note, this list is not comprehensive and all dates are subject to change. Monday Notable Earnings Halliburton Company (NYSE: ...

  • Why Agenus Inc. Stock Slumped Today
    Motley Fool4 days ago

    Why Agenus Inc. Stock Slumped Today

    Agenus' $250 million mixed shelf offering caused investors to hit the exits today.

  • Capital Cube25 days ago

    ETFs with exposure to Agenus, Inc. : September 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Agenus, Inc. Here are 5 ETFs with the largest exposure to AGEN-US. Comparing the performance and risk of Agenus, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Agenus (AGEN) Remains Focused on Drug Development Programs
    Zacks25 days ago

    Agenus (AGEN) Remains Focused on Drug Development Programs

    Agenus' (AGEN) collaboration agreements provide a steady source of funds to boost pipeline development.

  • Agenus, Inc. breached its 50 day moving average in a Bearish Manner : AGEN-US : September 22, 2017
    Capital Cubelast month

    Agenus, Inc. breached its 50 day moving average in a Bearish Manner : AGEN-US : September 22, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Agenus, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Reuterslast month

    'Impressed' FDA panel unanimously recommends GSK shingles vaccine

    A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 that the safety and efficacy of GlaxoSmithKline's Shingrix shingles vaccine warrants approval for its use in adults aged 50 and over. Panel members said they were "very impressed" by efficacy data from Shingrix clinical trials, and that it represents an improvement over Zostavax, the only marketed shingles prevention vaccine from Merck & Co. While the FDA is not required to follow recommendations of its advisory panels, the enthusiasm expressed would seem to indicate that approval is a virtual certainty in coming weeks.

  • Before You Buy Agenus Inc’s (AGEN), You Should Consider This
    Simply Wall St.last month

    Before You Buy Agenus Inc’s (AGEN), You Should Consider This

    For Agenus Inc’s (NASDAQ:AGEN) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. Broadly speaking, there areRead More...

  • Capital Cubelast month

    ETFs with exposure to Agenus, Inc. : September 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Agenus, Inc. Here are 5 ETFs with the largest exposure to AGEN-US. Comparing the performance and risk of Agenus, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Agenus, Inc. breached its 50 day moving average in a Bullish Manner : AGEN-US : September 11, 2017
    Capital Cubelast month

    Agenus, Inc. breached its 50 day moving average in a Bullish Manner : AGEN-US : September 11, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Agenus, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more (Read more...)

  • Why Is Agenus (AGEN) Down 11.8% Since the Last Earnings Report?
    Zacks2 months ago

    Why Is Agenus (AGEN) Down 11.8% Since the Last Earnings Report?

    Agenus (AGEN) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Capital Cube2 months ago

    ETFs with exposure to Agenus, Inc. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Agenus, Inc. Here are 5 ETFs with the largest exposure to AGEN-US. Comparing the performance and risk of Agenus, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Agenus, Inc. :AGEN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube2 months ago

    Agenus, Inc. :AGEN-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis Agenus, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Agenus, Inc. – Idera Pharmaceuticals, Inc., Cascadian Therapeutics Inc., GlaxoSmithKline plc Sponsored ADR, Merck & Co., Inc., Johnson & Johnson, ImmunoCellular Therapeutics, Ltd., Bristol-Myers Squibb Company, Celldex Therapeutics, Inc. ... Read more (Read more...)

  • 3 Top Biotech Stocks Under $5
    Motley Fool2 months ago

    3 Top Biotech Stocks Under $5

    Shares of Geron Corporation, Rigel Pharmaceuticals Inc., and Agenus Inc. appear to be trading for much less than they could be worth.

  • Agenus, Inc. – Value Analysis (NASDAQ:AGEN) : August 18, 2017
    Capital Cube2 months ago

    Agenus, Inc. – Value Analysis (NASDAQ:AGEN) : August 18, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Agenus, Inc. a score of 18. Our analysis is based on comparing Agenus, Inc. with the following peers – Idera Pharmaceuticals, Inc., Cascadian Therapeutics Inc., Northwest Biotherapeutics, Inc., GlaxoSmithKline plc Sponsored ADR, Merck & Co., Inc., Johnson & Johnson, ImmunoCellular Therapeutics, Ltd., Bristol-Myers Squibb Company, Celldex Therapeutics, ... Read more (Read more...)

  • 3 Beaten-Up Biotech Stocks: Are They Bargains?
    Motley Fool2 months ago

    3 Beaten-Up Biotech Stocks: Are They Bargains?

    It's been a pretty good year for biotech, but these three stocks have tumbled. Is the pessimism overblown?

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of AGEN earnings conference call or presentation 3-Aug-17 3:00pm GMT

    Q2 2017 Agenus Inc Earnings Call

  • Agenus, Inc. breached its 50 day moving average in a Bearish Manner : AGEN-US : August 7, 2017
    Capital Cube3 months ago

    Agenus, Inc. breached its 50 day moving average in a Bearish Manner : AGEN-US : August 7, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Agenus, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • Here's Why Agenus Inc. Stock Slipped 13.6% in July
    Motley Fool3 months ago

    Here's Why Agenus Inc. Stock Slipped 13.6% in July

    A big-pharma peer's clinical-trial failure cast a dark shadow over Agenus Inc.'s future.

  • Agenus (AGEN) Q2 Loss Narrower Than Expected, Revenues Lag
    Zacks3 months ago

    Agenus (AGEN) Q2 Loss Narrower Than Expected, Revenues Lag

    Agenus Inc. (AGEN) witnesses narrower-than-expected loss and also misses revenue estimates. However, the company is progressing well with the candidates in its pipeline in Q2.

  • Associated Press3 months ago

    Agenus reports 2Q loss

    On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 32 cents. The biotechnology company posted revenue of $4.2 million in the period. The company's shares closed at $4.12. ...

  • Agenus (AGEN) Reports Narrower-than-Expected Q2 Loss
    Zacks3 months ago

    Agenus (AGEN) Reports Narrower-than-Expected Q2 Loss

    Agenus reported narrower-than-expected loss in the second quarter of 2017 but revenues missed expectations.

  • Cramer Remix: The oil market is alive and may be ready to...
    CNBC Videos26 minutes ago

    Cramer Remix: The oil market is alive and may be ready to...

    Jim Cramer drilled into Schlumberger’s stock and what the company’s latest commentary means for the industry as a whole.

  • Agenus CEO: Shingles provides a 'multi-billion-dollar pro...
    CNBC Videos41 minutes ago

    Agenus CEO: Shingles provides a 'multi-billion-dollar pro...

    Jim Cramer sat down with Garo Armen, the CEO of small-cap biotech Agenus, to speak about his company's pipeline and cell therapies.